These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 6887461

  • 1. Antibody response following measles-mumps-rubella vaccine under conditions of customary use.
    Brunell PA, Weigle K, Murphy MD, Shehab Z, Cobb E.
    JAMA; 1983 Sep 16; 250(11):1409-12. PubMed ID: 6887461
    [Abstract] [Full Text] [Related]

  • 2. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan 16; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reactogenicity and immunogenicity of a new combined measles-mumps-rubella vaccine: results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines.
    Crovari P, Gabutti G, Giammanco G, Dentico P, Moiraghi AR, Ponzio F, Soncini R.
    Vaccine; 2000 Jun 15; 18(25):2796-803. PubMed ID: 10812221
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serological evaluation of a measles, mumps, and rubella vaccine.
    Robertson CM, Bennett VJ, Jefferson N, Mayon-White RT.
    Arch Dis Child; 1988 Jun 15; 63(6):612-6. PubMed ID: 3291787
    [Abstract] [Full Text] [Related]

  • 10. Low mumps antibody levels induced by mumps-measles-rubella vaccinations in type 1 diabetic children.
    Hiltunen M, Hyöty H, Leinikki P, Akerblom HK, Tuomilehto J, Vesikari T.
    Diabet Med; 1994 Dec 15; 11(10):942-6. PubMed ID: 7895458
    [Abstract] [Full Text] [Related]

  • 11. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L, Germann D, Bally F, Schopfer K.
    Eur J Epidemiol; 1997 Jan 15; 13(1):61-6. PubMed ID: 9062781
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunogenicity and reactogenicity of indigenously produced MMR vaccine.
    Bhargava I, Chhaparwal BC, Phadke MA, Irani SF, Chhaparwal D, Dhorje S, Maheshwari CP.
    Indian Pediatr; 1995 Sep 15; 32(9):983-8. PubMed ID: 8935261
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland.
    Narayan KM, Moffat MA.
    Health Bull (Edinb); 1992 Jan 15; 50(1):47-53. PubMed ID: 1612895
    [Abstract] [Full Text] [Related]

  • 18. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis.
    Flynn JT, Frisch K, Kershaw DB, Sedman AB, Bunchman TE.
    Adv Perit Dial; 1999 Jan 15; 15():269-72. PubMed ID: 10682116
    [Abstract] [Full Text] [Related]

  • 19. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.